Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.01 - $7.45 $31,890 - $78,932
10,595 New
10,595 $55,000
Q2 2023

Aug 11, 2023

SELL
$4.3 - $9.48 $139,135 - $306,744
-32,357 Reduced 45.89%
38,146 $263,000
Q1 2023

May 15, 2023

SELL
$4.81 - $8.88 $271,466 - $501,169
-56,438 Reduced 80.05%
14,065 $87,000
Q4 2022

Aug 11, 2023

BUY
$6.52 - $8.05 $1,010 - $1,247
155 Added 0.22%
70,503 $504,000
Q4 2022

Feb 13, 2023

BUY
$6.52 - $8.05 $1,010 - $1,247
155 Added 0.22%
70,503 $504,000
Q3 2022

Aug 11, 2023

SELL
$7.57 - $12.5 $5,912 - $9,762
-781 Reduced 1.1%
70,348 $544,000
Q3 2022

Nov 03, 2022

SELL
$7.57 - $12.5 $5,912 - $9,762
-781 Reduced 1.1%
70,348 $537,000
Q2 2022

Aug 11, 2023

BUY
$5.04 - $9.48 $136,896 - $257,495
27,162 Added 61.78%
71,129 $543,000
Q2 2022

Aug 15, 2022

BUY
$5.04 - $9.48 $136,896 - $257,495
27,162 Added 61.78%
71,129 $559,000
Q1 2022

Aug 11, 2023

BUY
$7.09 - $89.45 $212,005 - $2.67 Million
29,902 Added 212.6%
43,967 $339,000
Q1 2022

May 20, 2022

BUY
$7.09 - $89.45 $189,061 - $2.39 Million
26,666 Added 154.13%
43,967 $340,000
Q4 2021

Feb 16, 2022

SELL
$80.85 - $128.49 $10,672 - $16,960
-132 Reduced 0.76%
17,301 $1.52 Million
Q3 2021

Nov 12, 2021

SELL
$81.97 - $106.94 $136,316 - $177,841
-1,663 Reduced 8.71%
17,433 $1.67 Million
Q2 2021

Aug 12, 2021

BUY
$77.2 - $126.54 $32,115 - $52,640
416 Added 2.23%
19,096 $1.78 Million
Q1 2021

May 03, 2021

SELL
$110.45 - $164.47 $82,947 - $123,516
-751 Reduced 3.86%
18,680 $2.12 Million
Q4 2020

Feb 12, 2021

BUY
$60.78 - $154.03 $138,882 - $351,958
2,285 Added 13.33%
19,431 $2.86 Million
Q3 2020

Nov 09, 2020

SELL
$45.05 - $59.27 $13,154 - $17,306
-292 Reduced 1.67%
17,146 $1.02 Million
Q2 2020

Aug 10, 2020

SELL
$42.74 - $66.25 $17,138 - $26,566
-401 Reduced 2.25%
17,438 $936,000
Q1 2020

May 15, 2020

BUY
$38.18 - $73.95 $121,336 - $235,013
3,178 Added 21.68%
17,839 $851,000
Q4 2019

Feb 14, 2020

SELL
$13.9 - $76.65 $19,168 - $105,700
-1,379 Reduced 8.6%
14,661 $1.06 Million
Q3 2019

Nov 12, 2019

BUY
$10.24 - $17.57 $10 - $17
1 Added 0.01%
16,040 $226,000
Q2 2019

Aug 14, 2019

BUY
$6.2 - $12.0 $99,441 - $192,468
16,039 New
16,039 $188,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $455M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.